ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 212446 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 212446; 2) Community: the network communities that were significantly associated with the response to NSC 212446; 3) Molecule: the relationships between components within communities and NSC 212446; 4) MDR: the compounds that were significantly associated with the NSC 212446.

NSC Compound Enrichment Correlation
NSC 757113 METHOTREXATE(+/-) 0.00272369215216526 0.49018108
NSC 88915 Null 0.00272369215216526 0.34694512
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0027236921521653 0.51810035
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0027236921521653 0.43510126
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.00336064452966828 -0.37174845
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.00336064452966828 0.45656621
NSC 703442 Null 0.00336064452966828 0.25194969
NSC 627506 Null 0.00356914129105577 0.31973253
NSC 633273 ANTINEOPLASTIC-633273 0.00356914129105577 0.45123186
NSC 637126 Null 0.00356914129105577 0.55349071
Total:135  Current:22    [First] [Prev] [Next] [Last]